vs

Side-by-side financial comparison of Finance of America Companies Inc. (FOA) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Health Catalyst, Inc. is the larger business by last-quarter revenue ($74.7M vs $73.5M, roughly 1.0× Finance of America Companies Inc.). Finance of America Companies Inc. runs the higher net margin — -14.1% vs -121.9%, a 107.8% gap on every dollar of revenue. On growth, Finance of America Companies Inc. posted the faster year-over-year revenue change (248.7% vs -6.2%). Over the past eight quarters, Health Catalyst, Inc.'s revenue compounded faster (-0.0% CAGR vs -0.8%).

Rocket Companies, Inc., is an American fintech and homeownership services company. Founded by Dan Gilbert and based in Downtown Detroit, Michigan, the company is one of the largest mortgage lenders in the United States through its flagship subsidiary Rocket Mortgage. Its subsidiaries include Redfin, Forsalebyowner.com, and Rocket Money.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

FOA vs HCAT — Head-to-Head

Bigger by revenue
HCAT
HCAT
1.0× larger
HCAT
$74.7M
$73.5M
FOA
Growing faster (revenue YoY)
FOA
FOA
+254.9% gap
FOA
248.7%
-6.2%
HCAT
Higher net margin
FOA
FOA
107.8% more per $
FOA
-14.1%
-121.9%
HCAT
Faster 2-yr revenue CAGR
HCAT
HCAT
Annualised
HCAT
-0.0%
-0.8%
FOA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FOA
FOA
HCAT
HCAT
Revenue
$73.5M
$74.7M
Net Profit
$-10.4M
$-91.0M
Gross Margin
Operating Margin
-29.9%
-115.3%
Net Margin
-14.1%
-121.9%
Revenue YoY
248.7%
-6.2%
Net Profit YoY
82.4%
-340.3%
EPS (diluted)
$0.45
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FOA
FOA
HCAT
HCAT
Q4 25
$73.5M
$74.7M
Q3 25
$80.8M
$76.3M
Q2 25
$177.4M
$80.7M
Q1 25
$165.7M
$79.4M
Q4 24
$-49.4M
$79.6M
Q3 24
$290.1M
$76.4M
Q2 24
$79.0M
$75.9M
Q1 24
$74.7M
$74.7M
Net Profit
FOA
FOA
HCAT
HCAT
Q4 25
$-10.4M
$-91.0M
Q3 25
$-9.5M
$-22.2M
Q2 25
$34.9M
$-41.0M
Q1 25
$30.2M
$-23.7M
Q4 24
$-59.1M
$-20.7M
Q3 24
$84.2M
$-14.7M
Q2 24
$-2.1M
$-13.5M
Q1 24
$-7.5M
$-20.6M
Gross Margin
FOA
FOA
HCAT
HCAT
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
FOA
FOA
HCAT
HCAT
Q4 25
-29.9%
-115.3%
Q3 25
-35.3%
-22.9%
Q2 25
46.2%
-46.0%
Q1 25
49.3%
-25.4%
Q4 24
295.0%
-22.0%
Q3 24
71.8%
-17.9%
Q2 24
-4.8%
-20.8%
Q1 24
-21.1%
-30.5%
Net Margin
FOA
FOA
HCAT
HCAT
Q4 25
-14.1%
-121.9%
Q3 25
-11.8%
-29.1%
Q2 25
19.7%
-50.8%
Q1 25
18.2%
-29.9%
Q4 24
119.5%
-26.0%
Q3 24
29.0%
-19.3%
Q2 24
-2.6%
-17.8%
Q1 24
-10.1%
-27.6%
EPS (diluted)
FOA
FOA
HCAT
HCAT
Q4 25
$0.45
$-1.29
Q3 25
$-1.27
$-0.32
Q2 25
$2.13
$-0.59
Q1 25
$2.43
$-0.35
Q4 24
$-5.24
$-0.33
Q3 24
$7.50
$-0.24
Q2 24
$-0.30
$-0.23
Q1 24
$-0.78
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FOA
FOA
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$89.5M
$95.7M
Total DebtLower is stronger
$357.5M
$153.3M
Stockholders' EquityBook value
$395.6M
$245.8M
Total Assets
$30.7B
$502.6M
Debt / EquityLower = less leverage
0.90×
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FOA
FOA
HCAT
HCAT
Q4 25
$89.5M
$95.7M
Q3 25
$109.8M
$91.5M
Q2 25
$46.5M
$97.3M
Q1 25
$52.0M
$342.0M
Q4 24
$47.4M
$392.0M
Q3 24
$44.3M
$387.3M
Q2 24
$46.5M
$308.3M
Q1 24
$48.2M
$327.8M
Total Debt
FOA
FOA
HCAT
HCAT
Q4 25
$357.5M
$153.3M
Q3 25
$390.0M
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$374.5M
$382.4M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
FOA
FOA
HCAT
HCAT
Q4 25
$395.6M
$245.8M
Q3 25
$365.8M
$331.9M
Q2 25
$473.4M
$347.5M
Q1 25
$394.9M
$376.8M
Q4 24
$315.7M
$365.2M
Q3 24
$456.5M
$355.0M
Q2 24
$251.3M
$357.0M
Q1 24
$255.7M
$357.2M
Total Assets
FOA
FOA
HCAT
HCAT
Q4 25
$30.7B
$502.6M
Q3 25
$30.7B
$587.1M
Q2 25
$30.1B
$616.2M
Q1 25
$29.7B
$891.5M
Q4 24
$29.2B
$858.9M
Q3 24
$29.0B
$813.0M
Q2 24
$28.0B
$691.7M
Q1 24
$27.7B
$695.1M
Debt / Equity
FOA
FOA
HCAT
HCAT
Q4 25
0.90×
0.62×
Q3 25
1.07×
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.19×
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FOA
FOA
HCAT
HCAT
Operating Cash FlowLast quarter
$-429.7M
$9.9M
Free Cash FlowOCF − Capex
$9.6M
FCF MarginFCF / Revenue
12.9%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FOA
FOA
HCAT
HCAT
Q4 25
$-429.7M
$9.9M
Q3 25
$-149.7M
$-464.0K
Q2 25
$-96.5M
$-9.0M
Q1 25
$-92.1M
$280.0K
Q4 24
$-423.8M
$-3.5M
Q3 24
$-81.4M
$6.2M
Q2 24
$-104.0M
$1.6M
Q1 24
$-132.2M
$10.3M
Free Cash Flow
FOA
FOA
HCAT
HCAT
Q4 25
$9.6M
Q3 25
$-719.0K
Q2 25
$-9.2M
Q1 25
$-390.0K
Q4 24
$-3.9M
Q3 24
$5.5M
Q2 24
$1.3M
Q1 24
$-132.7M
$10.1M
FCF Margin
FOA
FOA
HCAT
HCAT
Q4 25
12.9%
Q3 25
-0.9%
Q2 25
-11.4%
Q1 25
-0.5%
Q4 24
-4.9%
Q3 24
7.2%
Q2 24
1.7%
Q1 24
-177.7%
13.5%
Capex Intensity
FOA
FOA
HCAT
HCAT
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.8%
Q4 24
0.5%
Q3 24
0.9%
Q2 24
0.4%
Q1 24
0.6%
0.3%
Cash Conversion
FOA
FOA
HCAT
HCAT
Q4 25
Q3 25
Q2 25
-2.76×
Q1 25
-3.05×
Q4 24
Q3 24
-0.97×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FOA
FOA

Segment Continuing Operations$70.8M96%
Other$2.7M4%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons